在乳腺癌术后放疗（PMRT）中应用推注：意大利放射肿瘤学会和临床肿瘤学会（AIRO）乳腺癌组的全国性调查。

Using the Bolus in Post-mastectomy Radiation Therapy (PMRT): A National Survey on Behalf of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) Breast Cancer Group.

机构信息

Department of Radiation Oncology, SS. Annunziata Hospital, "G. D'Annunzio" University of Chieti, Chieti, Italy.

Department of Radiation Oncology, SS. Annunziata Hospital, "G. D'Annunzio" University of Chieti, Chieti, Italy

出版信息

Anticancer Res. 2020 Nov;40(11):6505-6511. doi: 10.21873/anticanres.14673.

DOI:10.21873/anticanres.14673

PMID:33109590

Abstract

BACKGROUND/AIM: This study aimed to investigate the bolus practice among Italian radiation oncologists.

PATIENTS AND METHODS

In 2018, a survey on bolus application was sent to all members of the Italian Association of Radiotherapy and Clinical Oncology.

RESULTS

The survey was joined by 102 radiation oncologists. Not all respondents answered to every question. A 69.5% of 82 respondents used bolus in case of skin infiltration and 52 of 68 respondents (76.5%) applied it every day. Skin was included as part of chest wall Clinical Target Volume both in the absence or the presence of breast reconstruction. Five mm bolus was the most used. 3D Conformal radiotherapy was the most used technique, in 73.5% of cases. Acute RTOG G2-G3 skin toxicity was recorded by 93.9% physicians.

CONCLUSION

There was heterogeneity in the use of bolus, though an agreement was found in some topics. The achievement of a National Consensus may represent an interesting future goal.

摘要

背景/目的：本研究旨在调查意大利放射肿瘤学家的推注实践。

患者和方法

2018 年，对推注应用情况的调查发送给了意大利放射治疗和临床肿瘤学协会的所有成员。

结果

该调查共有 102 名放射肿瘤学家参加。并非所有受访者都回答了每个问题。82 名受访者中有 69.5%（52 名）在皮肤浸润的情况下使用了推注，68 名受访者中有 52 名（76.5%）每天都使用。在没有或有乳房重建的情况下，皮肤均被包含在胸壁临床靶区中。最常使用的是 5mm 的推注。73.5%的病例中使用的是 3D 适形放疗。93.9%的医生记录了急性 RTOG G2-G3 皮肤毒性。